Back to Search
Start Over
A novel function for glucocerebrosidase as a regulator of sterylglucoside metabolism.
- Source :
-
Biochimica et biophysica acta. General subjects [Biochim Biophys Acta Gen Subj] 2017 Oct; Vol. 1861 (10), pp. 2507-2514. Date of Electronic Publication: 2017 Jun 06. - Publication Year :
- 2017
-
Abstract
- Background: Sterols are major cell membrane lipids, and in many organisms they are modified with glucose to generate sterylglucosides. Glucosylation dramatically changes the functional properties of sterols. The formation of sterylglucosides from sterols in plants, fungi, and bacteria uses UDP-glucose as a glucose donor. By contrast, sterylglucoside biosynthesis in mammals is catalyzed by the transglucosylation activity of glucocerebrosidases, with glucosylceramide acting as the glucose donor. Recent success in isolation and structural determination of sterylglucosides in the vertebrate central nervous system shows that transglucosylation also occurs in vivo. These analyses also revealed that sterylglucoside aglycons are composed of several cholesterol-related metabolites, including a plant-type sitosteryl.<br />Scope of Review: In this review, we discuss the biological functions and metabolism of sterylglucosides. We also summarize new findings from studies on the metabolism of vertebrate sterylglucosides and review the circumstances underlying the recent discovery of sterylglucosides in vertebrate brain. Finally, we discuss the role of sterylglucosides in a variety of neurodegenerative disorders such as Gaucher disease and Parkinson's disease.<br />Major Conclusions: The biological significance of UDP-glucose-independent sterol glucosylation is still unknown, but it is plausible that glucosylation may provide sterols with novel biological functions. Even though sterol glucosylation is a simple reaction, it can dramatically change the physical properties of sterols.<br />General Significance: Sterylglucosides may play roles in various physiological processes and in the pathogenesis of different diseases. Arriving at a better understanding of them at the organ and cellular level may open up new approaches to developing therapeutics for a variety of diseases. This article is part of a Special Issue entitled Neuro-glycoscience, edited by Kenji Kadomatsu and Hiroshi Kitagawa.<br /> (Copyright © 2017 Elsevier B.V. All rights reserved.)
- Subjects :
- Animals
Bacteria metabolism
Cholestenes chemistry
Cholesterol chemistry
Cholesterol metabolism
Fungi metabolism
Gaucher Disease genetics
Gaucher Disease pathology
Gene Expression
Glucosylceramidase genetics
Glucosylceramides chemistry
Humans
Parkinson Disease genetics
Parkinson Disease pathology
Phytosterols chemistry
Phytosterols metabolism
Plants metabolism
Uridine Diphosphate Glucose metabolism
Cholestenes metabolism
Gaucher Disease metabolism
Glucosylceramidase metabolism
Glucosylceramides metabolism
Parkinson Disease metabolism
Subjects
Details
- Language :
- English
- ISSN :
- 0304-4165
- Volume :
- 1861
- Issue :
- 10
- Database :
- MEDLINE
- Journal :
- Biochimica et biophysica acta. General subjects
- Publication Type :
- Academic Journal
- Accession number :
- 28596107
- Full Text :
- https://doi.org/10.1016/j.bbagen.2017.06.003